| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.1 |